2018•Chin J Reprod ContracepRequires access

Advances in the mechanism of G protein coupled estrogen receptor mediated estrogen therapy

Jiangshan Hu, Minfang Tao

Open publisher page 0 citations

Abstract

There will be a series of symptoms and diseases associated with estrogen deficiency after menopause, and the main treatment is menopause hormone therapy. In addition to the genomic effects of estrogen binding to the traditional nuclear receptors ERα and β, a recently discovered G protein-coupled estrogen receptor (GPER) has also confirmed the rapid effects of estrogen on target organs. In recent years, studies on GPER-mediated estrogen specific physiological functions in different target cells and its mechanism of action are emerging. This review summarizes the possible mechanisms of GPER mediated estrogen therapy in the treatment of menopausal symptoms and diseases from the aspects of reproductive system, nervous system, cardiovascular system, endocrine metabolism and bone metabolism. Key words: Menopause; Estrogen; G protein-coupled estrogen receptor (GPER); G protein-coupled receptor 30 (GPR30); Hormone replacement therapy

About this research paper

What this paper is about

There will be a series of symptoms and diseases associated with estrogen deficiency after menopause, and the main treatment is menopause hormone therapy. In addition to the genomic effects of estrogen binding to the traditional nuclear receptors ERα and β, a recently discovered G protein-coupled estrogen receptor (GPER) has also confirmed the rapid effects of estrogen on target organs. In recent years, studies on GPER-mediated estrogen specific physiological functions in different target cells and its mechanism of action are emerging. This review summarizes the possible mechanisms of GPER mediated estrogen therapy in the treatment of menopausal symptoms and diseases from the aspects of reproductive system, nervous system, cardiovascular system, endocrine metabolism and bone metabolism. Key words: Menopause; Estrogen; G protein-coupled estrogen receptor (GPER); G protein-coupled receptor 30 (GPR30); Hormone replacement therapy

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

There will be a series of symptoms and diseases associated with estrogen deficiency after menopause, and the main treatment is menopause hormone therapy. In addition to the genomic effects of estrogen binding to the traditional nuclear receptors ERα and β, a recently discovered G protein-coupled estrogen receptor (GPER) has also confirmed the rapid effects of estrogen on target organs. In recent years, studies on GPER-mediated estrogen specific physiological functions in different target cells and its mechanism of action are emerging. This review summarizes the possible mechanisms of GPER mediated estrogen therapy in the treatment of menopausal symptoms and diseases from the aspects of reproductive system, nervous system, cardiovascular system, endocrine metabolism and bone metabolism. Key words: Menopause; Estrogen; G protein-coupled estrogen receptor (GPER); G protein-coupled receptor 30 (GPR30); Hormone replacement therapy

Key concepts: GPER, Estrogen, Estrogen receptor, Menopause, Estrogen receptor beta, Endocrinology, Internal medicine, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Advances in the mechanism of G protein coupled estrogen receptor mediated estrogen therapy — Research Paper | ScholarLens